Last updated: April 21, 2026

Application No. 19/407,221

Untitled Application

Unknown

Filed

1600

Examiner

TRAN, SUSAN T

Art Unit

1615

Tech Center

MIRATI THERAPEUTICS, INC.

Assignee

Mirati Therapeutics Inc.

OA Round

1 (Non-Final)

This examiner grants 63% of cases after interview

— +35.9% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 1009 resolved cases, 2023–2026

Examiner Intelligence

TRAN, SUSAN T View full profile →

Grants 63% of resolved cases

Career Allow Rate

632 granted / 1009 resolved

+2.6% vs TC avg

Strong +36% interview lift

Without

With

+35.9%

Interview Lift

resolved cases with interview

Typical timeline

3y 4m

Avg Prosecution

52 currently pending

Career history

1061

Total Applications

across all art units

Statute-Specific Performance

§101

0.3%

-39.7% vs TC avg

§103

39.1%

-0.9% vs TC avg

§102

22.7%

-17.3% vs TC avg

§112

21.5%

-18.5% vs TC avg

Black line = Tech Center average estimate • Based on career data from 1009 resolved cases

Prosecution Timeline

1600

Application Filed

Feb 07, 2026

Non-Final Rejection

Mar 31, 2026

Interview Requested

Apr 08, 2026

Interview Requested

Precedent Cases

Applications granted by this same examiner with similar technology

17/835,435

Patent 12599598

OSMOTIC DOSAGE FORMS COMPRISING DEUTETRABENAZINE AND METHODS OF USE THEREOF

3y 10m to grant Granted Apr 14, 2026

18/013,801

Patent 12600718

METHOD FOR PREPARING COMPOUND AS PI3K INHIBITOR AND INTERMEDIATE COMPOUND FOR PREPARING SAME

3y 3m to grant Granted Apr 14, 2026

18/024,452

Patent 12599697

Liquid Embolic Compositions with Controlled Release of Radiopaque and Therapeutic Compounds and Methods of Using the Same

3y 1m to grant Granted Apr 14, 2026

18/609,809

Patent 12589075

OSMOTIC DOSAGE FORMS COMPRISING DEUTETRABENAZINE AND METHODS OF USE THEREOF

2y 0m to grant Granted Mar 31, 2026

18/363,002

Patent 12568965

ANTIMICROBIAL COMPOSITION COMPRISING AN ALKYLDIMETHYLBENZYLAMMONIUM COMPOUND

2y 7m to grant Granted Mar 10, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

63%

Grant Probability

98%

With Interview (+35.9%)

3y 4m

Median Time to Grant

Low

PTA Risk

Based on 1009 resolved cases by this examiner. Grant probability derived from career allow rate.